SCHEMBL6764276

SCHEMBL6764276

CC1(C)Cc2cc(O)c(C(C)(C)C)cc2O1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
ALOX15 P16050 5/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45
CYP1A2 P05177 1/20 0.45
ATP2A2 P16615 1/20 0.45
ATP2A3 Q93084 1/20 0.45
TP53 P04637 3/20 0.36
LMNA P02545 2/20 0.36
CYP3A4 P08684 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 2/20 0.35
CYP2C9 P11712 2/20 0.35
NR1I2 O75469 1/20 0.35
MIF P14174 1/20 0.35
TYR P14679 1/20 0.35
NFE2L2 Q16236 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1151712 0.84 ALOX15 (0.42) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL6313672 0.78 KDM4E (0.40) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL11703740 0.76 ALOX15 (0.41) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL28339856 0.75 ALOX15 (0.40) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL6767599 0.74 PTPN1 (0.37) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL19046335 0.74 ALDH1A1 (0.42) ALDH1A1ALOX15KDM4EMAPTCYP1A2
SCHEMBL10846677 0.73 CNR2 (0.38) ALDH1A1SMN1; SMN2MAPTLMNATSHR
SCHEMBL4462820 0.73 ALOX15 (0.41) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL11705197 0.73 BCHE (0.41) ALDH1A1ALOX15SMN1; SMN2KDM4EMAPT
SCHEMBL19045852 0.72 ALDH1A1 (0.41) ALDH1A1ALOX15KDM4EMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686389-B2 KIDNEY DISEASE, ORGAN TRANSPLANT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2004-02-03 US disclosed
US-20020156296-A1 2,3-dihydrobenzofuran derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-10-24 US disclosed
US-6403639-B1 POTENT CYTOPROTECTIVE AGENT WHICH INHIBITS LIPID-PEROXIDATION FOR PREVENTION AND TREATMENT OF VARIOUS RENAL DISEASES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-06-11 US disclosed
EP-0995437-A1 2,3-DIHYDROBENZOFURAN DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-04-26 EP disclosed
US-4855278-A Heat-sensitive recording material FUJI PHOTO FILM CO., LTD. (JP) 1989-08-08 US disclosed
US-4727056-A Recording material FUJI PHOTO FILM CO., LTD. (JP) 1988-02-23 US disclosed
US-4707464-A Recording material FUJI PHOTO FILM CO., LTD. (JP) 1987-11-17 US disclosed
US-4603339-A Recording material FUJI PHOTO FILM CO., LTD. (JP) 1986-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156296-A1 2,3-dihydrobenzofuran derivatives CBR1, CYP2F1, NDUFAF2 ALDH1A1 7/4885ALOX15 887/4885SMN1; SMN2 1237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.